Cell-based Flu Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Cell-based Flu Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell-based Flu Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell-based Flu Vaccine Overall Market Size
2.1 Global Cell-based Flu Vaccine Market Size: 2021 VS 2028
2.2 Global Cell-based Flu Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Cell-based Flu Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Cell-based Flu Vaccine Players in Global Market
3.2 Top Global Cell-based Flu Vaccine Companies Ranked by Revenue
3.3 Global Cell-based Flu Vaccine Revenue by Companies
3.4 Global Cell-based Flu Vaccine Sales by Companies
3.5 Global Cell-based Flu Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Cell-based Flu Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Cell-based Flu Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cell-based Flu Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Cell-based Flu Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Cell-based Flu Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell-based Flu Vaccine Market Size Markets, 2021 & 2028
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - Global Cell-based Flu Vaccine Revenue & Forecasts
4.2.1 By Type - Global Cell-based Flu Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Cell-based Flu Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Cell-based Flu Vaccine Sales & Forecasts
4.3.1 By Type - Global Cell-based Flu Vaccine Sales, 2017-2022
4.3.2 By Type - Global Cell-based Flu Vaccine Sales, 2023-2028
4.3.3 By Type - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Cell-based Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Cell-based Flu Vaccine Market Size, 2021 & 2028
5.1.2 Aldults
5.1.3 Children
5.2 By Application - Global Cell-based Flu Vaccine Revenue & Forecasts
5.2.1 By Application - Global Cell-based Flu Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Cell-based Flu Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Cell-based Flu Vaccine Sales & Forecasts
5.3.1 By Application - Global Cell-based Flu Vaccine Sales, 2017-2022
5.3.2 By Application - Global Cell-based Flu Vaccine Sales, 2023-2028
5.3.3 By Application - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Cell-based Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Cell-based Flu Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Cell-based Flu Vaccine Revenue & Forecasts
6.2.1 By Region - Global Cell-based Flu Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Cell-based Flu Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Cell-based Flu Vaccine Sales & Forecasts
6.3.1 By Region - Global Cell-based Flu Vaccine Sales, 2017-2022
6.3.2 By Region - Global Cell-based Flu Vaccine Sales, 2023-2028
6.3.3 By Region - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Cell-based Flu Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Cell-based Flu Vaccine Sales, 2017-2028
6.4.3 US Cell-based Flu Vaccine Market Size, 2017-2028
6.4.4 Canada Cell-based Flu Vaccine Market Size, 2017-2028
6.4.5 Mexico Cell-based Flu Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Cell-based Flu Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Cell-based Flu Vaccine Sales, 2017-2028
6.5.3 Germany Cell-based Flu Vaccine Market Size, 2017-2028
6.5.4 France Cell-based Flu Vaccine Market Size, 2017-2028
6.5.5 U.K. Cell-based Flu Vaccine Market Size, 2017-2028
6.5.6 Italy Cell-based Flu Vaccine Market Size, 2017-2028
6.5.7 Russia Cell-based Flu Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Cell-based Flu Vaccine Market Size, 2017-2028
6.5.9 Benelux Cell-based Flu Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Cell-based Flu Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Cell-based Flu Vaccine Sales, 2017-2028
6.6.3 China Cell-based Flu Vaccine Market Size, 2017-2028
6.6.4 Japan Cell-based Flu Vaccine Market Size, 2017-2028
6.6.5 South Korea Cell-based Flu Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Cell-based Flu Vaccine Market Size, 2017-2028
6.6.7 India Cell-based Flu Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Cell-based Flu Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Cell-based Flu Vaccine Sales, 2017-2028
6.7.3 Brazil Cell-based Flu Vaccine Market Size, 2017-2028
6.7.4 Argentina Cell-based Flu Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cell-based Flu Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Cell-based Flu Vaccine Sales, 2017-2028
6.8.3 Turkey Cell-based Flu Vaccine Market Size, 2017-2028
6.8.4 Israel Cell-based Flu Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Cell-based Flu Vaccine Market Size, 2017-2028
6.8.6 UAE Cell-based Flu Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Cell-based Flu Vaccine Major Product Offerings
7.1.4 GlaxoSmithKline Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Cell-based Flu Vaccine Major Product Offerings
7.2.4 Sanofi Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Cell-based Flu Vaccine Major Product Offerings
7.3.4 Pfizer Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 MedImmune, LLC
7.4.1 MedImmune, LLC Corporate Summary
7.4.2 MedImmune, LLC Business Overview
7.4.3 MedImmune, LLC Cell-based Flu Vaccine Major Product Offerings
7.4.4 MedImmune, LLC Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 MedImmune, LLC Key News
7.5 Intravacc
7.5.1 Intravacc Corporate Summary
7.5.2 Intravacc Business Overview
7.5.3 Intravacc Cell-based Flu Vaccine Major Product Offerings
7.5.4 Intravacc Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Intravacc Key News
7.6 CSL Limited
7.6.1 CSL Limited Corporate Summary
7.6.2 CSL Limited Business Overview
7.6.3 CSL Limited Cell-based Flu Vaccine Major Product Offerings
7.6.4 CSL Limited Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 CSL Limited Key News
7.7 E. Merck KG
7.7.1 E. Merck KG Corporate Summary
7.7.2 E. Merck KG Business Overview
7.7.3 E. Merck KG Cell-based Flu Vaccine Major Product Offerings
7.7.4 E. Merck KG Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 E. Merck KG Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Cell-based Flu Vaccine Major Product Offerings
7.8.4 Novartis Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Novartis Key News
7.9 Danaher Corporation
7.9.1 Danaher Corporation Corporate Summary
7.9.2 Danaher Corporation Business Overview
7.9.3 Danaher Corporation Cell-based Flu Vaccine Major Product Offerings
7.9.4 Danaher Corporation Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Danaher Corporation Key News
7.10 SINOVAC
7.10.1 SINOVAC Corporate Summary
7.10.2 SINOVAC Business Overview
7.10.3 SINOVAC Cell-based Flu Vaccine Major Product Offerings
7.10.4 SINOVAC Cell-based Flu Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 SINOVAC Key News
8 Global Cell-based Flu Vaccine Production Capacity, Analysis
8.1 Global Cell-based Flu Vaccine Production Capacity, 2017-2028
8.2 Cell-based Flu Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Cell-based Flu Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cell-based Flu Vaccine Supply Chain Analysis
10.1 Cell-based Flu Vaccine Industry Value Chain
10.2 Cell-based Flu Vaccine Upstream Market
10.3 Cell-based Flu Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cell-based Flu Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Cell-based Flu Vaccine in Global Market
Table 2. Top Cell-based Flu Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Cell-based Flu Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Cell-based Flu Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Cell-based Flu Vaccine Sales by Companies, (M Doses), 2017-2022
Table 6. Global Cell-based Flu Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Cell-based Flu Vaccine Price (2017-2022) & (US$/Dose)
Table 8. Global Manufacturers Cell-based Flu Vaccine Product Type
Table 9. List of Global Tier 1 Cell-based Flu Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell-based Flu Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Cell-based Flu Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Cell-based Flu Vaccine Sales (M Doses), 2017-2022
Table 15. By Type - Global Cell-based Flu Vaccine Sales (M Doses), 2023-2028
Table 16. By Application ? Global Cell-based Flu Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Cell-based Flu Vaccine Sales (M Doses), 2017-2022
Table 20. By Application - Global Cell-based Flu Vaccine Sales (M Doses), 2023-2028
Table 21. By Region ? Global Cell-based Flu Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Cell-based Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Cell-based Flu Vaccine Sales (M Doses), 2017-2022
Table 25. By Region - Global Cell-based Flu Vaccine Sales (M Doses), 2023-2028
Table 26. By Country - North America Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 29. By Country - North America Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 30. By Country - Europe Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 33. By Country - Europe Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 34. By Region - Asia Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 37. By Region - Asia Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 38. By Country - South America Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 41. By Country - South America Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 42. By Country - Middle East & Africa Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Cell-based Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Cell-based Flu Vaccine Sales, (M Doses), 2017-2022
Table 45. By Country - Middle East & Africa Cell-based Flu Vaccine Sales, (M Doses), 2023-2028
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Cell-based Flu Vaccine Product Offerings
Table 48. GlaxoSmithKline Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Cell-based Flu Vaccine Product Offerings
Table 51. Sanofi Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Cell-based Flu Vaccine Product Offerings
Table 54. Pfizer Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 55. MedImmune, LLC Corporate Summary
Table 56. MedImmune, LLC Cell-based Flu Vaccine Product Offerings
Table 57. MedImmune, LLC Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 58. Intravacc Corporate Summary
Table 59. Intravacc Cell-based Flu Vaccine Product Offerings
Table 60. Intravacc Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 61. CSL Limited Corporate Summary
Table 62. CSL Limited Cell-based Flu Vaccine Product Offerings
Table 63. CSL Limited Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 64. E. Merck KG Corporate Summary
Table 65. E. Merck KG Cell-based Flu Vaccine Product Offerings
Table 66. E. Merck KG Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Cell-based Flu Vaccine Product Offerings
Table 69. Novartis Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 70. Danaher Corporation Corporate Summary
Table 71. Danaher Corporation Cell-based Flu Vaccine Product Offerings
Table 72. Danaher Corporation Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 73. SINOVAC Corporate Summary
Table 74. SINOVAC Cell-based Flu Vaccine Product Offerings
Table 75. SINOVAC Cell-based Flu Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2017-2022)
Table 76. Cell-based Flu Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2020-2022 (M Doses)
Table 77. Global Cell-based Flu Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Cell-based Flu Vaccine Production by Region, 2017-2022 (M Doses)
Table 79. Global Cell-based Flu Vaccine Production by Region, 2023-2028 (M Doses)
Table 80. Cell-based Flu Vaccine Market Opportunities & Trends in Global Market
Table 81. Cell-based Flu Vaccine Market Drivers in Global Market
Table 82. Cell-based Flu Vaccine Market Restraints in Global Market
Table 83. Cell-based Flu Vaccine Raw Materials
Table 84. Cell-based Flu Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Cell-based Flu Vaccine Downstream
Table 86. Cell-based Flu Vaccine Downstream Clients in Global Market
Table 87. Cell-based Flu Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cell-based Flu Vaccine Segment by Type
Figure 2. Cell-based Flu Vaccine Segment by Application
Figure 3. Global Cell-based Flu Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cell-based Flu Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cell-based Flu Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Cell-based Flu Vaccine Sales in Global Market: 2017-2028 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Cell-based Flu Vaccine Revenue in 2021
Figure 9. By Type - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Cell-based Flu Vaccine Price (US$/Dose), 2017-2028
Figure 12. By Application - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Cell-based Flu Vaccine Price (US$/Dose), 2017-2028
Figure 15. By Region - Global Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 19. US Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 33. China Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Cell-based Flu Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Cell-based Flu Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Cell-based Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Cell-based Flu Vaccine Production Capacity (M Doses), 2017-2028
Figure 49. The Percentage of Production Cell-based Flu Vaccine by Region, 2021 VS 2028
Figure 50. Cell-based Flu Vaccine Industry Value Chain
Figure 51. Marketing Channels
Industry Market Size
